IL125982A - Modules-2 (Arylphenyl) Amino-imidazoline, their preparation and pharmaceutical preparations containing them - Google Patents

Modules-2 (Arylphenyl) Amino-imidazoline, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL125982A
IL125982A IL12598298A IL12598298A IL125982A IL 125982 A IL125982 A IL 125982A IL 12598298 A IL12598298 A IL 12598298A IL 12598298 A IL12598298 A IL 12598298A IL 125982 A IL125982 A IL 125982A
Authority
IL
Israel
Prior art keywords
compound
phenyl
amino
imidazoline
formula
Prior art date
Application number
IL12598298A
Other languages
English (en)
Hebrew (he)
Other versions
IL125982A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL125982A0 publication Critical patent/IL125982A0/xx
Publication of IL125982A publication Critical patent/IL125982A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lenses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL12598298A 1997-09-04 1998-08-28 Modules-2 (Arylphenyl) Amino-imidazoline, their preparation and pharmaceutical preparations containing them IL125982A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5780897P 1997-09-04 1997-09-04
US8991698P 1998-06-19 1998-06-19

Publications (2)

Publication Number Publication Date
IL125982A0 IL125982A0 (en) 1999-04-11
IL125982A true IL125982A (en) 2002-09-12

Family

ID=26736908

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12598298A IL125982A (en) 1997-09-04 1998-08-28 Modules-2 (Arylphenyl) Amino-imidazoline, their preparation and pharmaceutical preparations containing them

Country Status (18)

Country Link
EP (1) EP0902018B1 (fr)
JP (1) JP3040752B2 (fr)
KR (1) KR100309191B1 (fr)
CN (1) CN1110484C (fr)
AT (1) ATE402151T1 (fr)
AU (1) AU746480B2 (fr)
CA (1) CA2245755A1 (fr)
CZ (1) CZ278198A3 (fr)
DE (1) DE69839753D1 (fr)
DK (1) DK0902018T3 (fr)
HU (1) HUP9801950A3 (fr)
IL (1) IL125982A (fr)
MA (1) MA26541A1 (fr)
NO (1) NO312294B1 (fr)
NZ (1) NZ331480A (fr)
PT (1) PT902018E (fr)
RU (1) RU2211834C2 (fr)
TW (1) TW432046B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU68102A (sh) 2000-03-16 2006-01-16 F. Hoffmann-La Roche Ag. Derivati karboksilne kiseline kao ip antagonisti
ATE319696T1 (de) * 2000-08-08 2006-03-15 Ortho Mcneil Pharm Inc Nicht-imidazol aryloxyalkylamine als h3 rezeptor liganden
JP4909487B2 (ja) * 2000-08-30 2012-04-04 学校法人神奈川大学 オキセタン変性化合物とそれから誘導される光硬化性化合物、それらの製造方法及びそれらを含有する硬化性組成物
MXPA03004073A (es) * 2000-11-14 2003-09-04 Hoffmann La Roche Derivados de 2-fenilaminoimidazolina fenil cetona sustituidos como antagonistas de ip.
WO2004071508A1 (fr) * 2003-02-14 2004-08-26 Medical Research Council Antagonistes du recepteur ip utilises dans le traitement des pathologies de l'uterus
KR100777876B1 (ko) * 2003-05-01 2007-11-28 에프. 호프만-라 로슈 아게 프로스타글란딘 ｉ2(ｉｐ) 길항제로서 이미다졸린-2-일아미노페닐 아마이드
MXPA06000269A (es) * 2003-07-09 2006-04-07 Hoffmann La Roche Tiofenilaminoimidazolinas.
EP2513064B1 (fr) 2009-12-17 2018-07-04 Katholieke Universiteit Leuven K.U. Leuven R&D Composé, compositions et procédés de lutte contre les biofilms
US9452980B2 (en) * 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
EP2600864B1 (fr) * 2010-08-04 2019-01-09 University Of Virginia Patent Foundation Compositions et procédés pour le traitement de maladies inflammatoires
JP2015530378A (ja) * 2012-08-29 2015-10-15 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 変形性関節症の処置のためのｄｄｒ２インヒビター
WO2014143592A1 (fr) 2013-03-12 2014-09-18 Allergan, Inc. Inhibition de la néovascularisation par inhibition des récepteurs de prostanoïde ip
WO2014143591A1 (fr) 2013-03-12 2014-09-18 Allergan, Inc. Inhibition de la néovascularisation par inhibition simultanée de prostanoïde ip et des récepteurs ep4
WO2016043260A1 (fr) * 2014-09-19 2016-03-24 塩野義製薬株式会社 Composé d'amidine ou de guanidine cyclique
US9827225B2 (en) 2016-01-25 2017-11-28 Jenivision Inc. Use of prostacyclin antagonists for treating ocular surface nociception

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7711390A (nl) * 1977-10-18 1979-04-20 Philips Nv Nieuwe 2-arylimino-hexahydopyrimidinen en - imi- dazolidinen, zouten en complexen daarvan, werk- wijze ter bereiding van de nieuwe verbindingen, alsmede fungicide preparaten op basis van de nieuwe verbindingen.
NL7810350A (nl) * 1978-10-16 1980-04-18 Duphar Int Res Preparaat met groeiregulerende werking en gebruik van dit preparaat in land- en tuinbouw.
CA1138451A (fr) * 1979-04-03 1982-12-28 Fujisawa Pharmaceutical Co., Ltd. Derives de la 2-imidazoline, procede de preparation et composes pharmaceutiques les contenant
US4287201A (en) * 1980-03-03 1981-09-01 Merck & Co., Inc. Anovulatory method and chicken feed compositions
US4889868A (en) * 1984-12-20 1989-12-26 Rorer Pharmaceutical Corporation Bis-imidazolinoamino derivatives as antiallergy compounds
CA2003283A1 (fr) * 1988-12-05 1990-06-05 C. Anne Higley Imidazoles pour le traitement de l'atherosclerose
WO1993017681A1 (fr) * 1992-03-02 1993-09-16 Abbott Laboratories Antagonistes du recepteur d'angiotensine ii
GB9506188D0 (en) * 1995-03-27 1995-05-17 Fujisawa Pharmaceutical Co Amidine derivatives
FR2761061B1 (fr) * 1997-03-20 1999-04-23 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
HU9801950D0 (en) 1998-10-28
PT902018E (pt) 2008-09-05
TW432046B (en) 2001-05-01
RU2211834C2 (ru) 2003-09-10
CN1110484C (zh) 2003-06-04
MA26541A1 (fr) 2004-12-20
JPH11140057A (ja) 1999-05-25
HUP9801950A2 (hu) 1999-03-29
AU746480B2 (en) 2002-05-02
KR19990029550A (ko) 1999-04-26
NO984044D0 (no) 1998-09-03
NZ331480A (en) 2000-02-28
JP3040752B2 (ja) 2000-05-15
NO984044L (no) 1999-03-05
CZ278198A3 (cs) 1999-04-14
CA2245755A1 (fr) 1999-03-04
NO312294B1 (no) 2002-04-22
EP0902018A3 (fr) 2001-05-02
EP0902018A2 (fr) 1999-03-17
ATE402151T1 (de) 2008-08-15
HK1019334A1 (en) 2000-02-03
EP0902018B1 (fr) 2008-07-23
HUP9801950A3 (en) 2001-12-28
KR100309191B1 (ko) 2001-12-12
AU8309498A (en) 1999-03-18
DK0902018T3 (da) 2008-10-20
CN1216762A (zh) 1999-05-19
IL125982A0 (en) 1999-04-11
DE69839753D1 (de) 2008-09-04

Similar Documents

Publication Publication Date Title
EP0902018B1 (fr) Dérivés de 2-(arylphényl)amino-imidazoline
US6472536B1 (en) 2-(substituted-phenyl)amino-imidazoline derivatives
JP4108474B2 (ja) Ｉｐアンタゴニストとしての置換２−フェニルアミノイミダゾリンフェニルケトン誘導体
KR20090079259A (ko) 5-ｈｔ6 억제제로서 아릴설폰일 피롤리딘
EP1379516B1 (fr) Derives d'acide alkoxycarbonylaminobenzoique ou d'alkoxycarbonylamino tetrazolyl phenyle comme antagonistes de ip
KR100768609B1 (ko) 티오페닐아미노이미다졸린
US6417186B1 (en) Substituted-phenyl ketone derivatives as IP antagonists
AU2002253061A1 (en) Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists
EP0298921B1 (fr) 1,2-Benzisoxazoles et 1,2-benzisothiazoles
MXPA98007126A (en) 2-(arylphenyl)amino-imidazoline derivatives
HRP980487A2 (en) 2-(arylphenyl)amino-imidazoline derivatives
AU2002221808B2 (en) Substituted 2-phenylaminoimidazoline Phenyl Ketone Derivatives as IP Antagonists
AU2002221808A1 (en) Substituted 2-phenylaminoimidazoline Phenyl Ketone Derivatives as IP Antagonists

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees